United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 4 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Akso Health Group? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | |||
|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -79.99% | -5.31% | -6.02% | -7.14% | -8.34% |
|---|---|---|---|---|---|
| ROA | -75.62% | -4.76% | -5.02% | -5.49% | -5.84% |
| Gross Margin | 5.06% | 15% | 15% | 15% | 15% |
| Net Margin | -913.38% | -64.23% | -62.02% | -63.89% | -64.04% |
| Total Assets | $214,953.33K | $218,056.87K | $221,427.86K | $225,055.08K | $228,958.25K |
| Net Income | -$134,977.37K | -$10,298.10K | -$11,034.52K | -$12,261.03K | -$13,249.90K |